#USA #Miami #RevGenetics #DiBerberine #Dihydroberberine

RevGenetics Innovations Target the Berberine Absorption Problem

In a bold move to revolutionize the metabolic support market, RevGenetics has officially launched DiBerberine 300x - a sophisticated supplement designed to tackle the well-recognized issue of berberine absorption. This solution significantly departs from traditional formulations, pushing the boundaries of what consumers can expect from dietary supplements.

The Absorption Crisis

The industry has long faced challenges regarding the bioavailability of berberine, a compound known for its metabolic benefits. Standard products often rely on basic vegetarian capsules that fall short in delivering the active ingredient effectively. RevGenetics aims to address the shortcomings exposed in numerous studies highlighting the “absorption gap” in popular berberine supplements. Founder Anthony Loera remarked, “We questioned why the supplement industry promotes AMPK activation while employing delivery methods that compromise this process.”

Introducing DiBerberine 300x

DiBerberine 300x distinguishes itself by utilizing an innovative enteric-coated dihydroberberine (DHB) formulation. This advanced technology provides two critical advantages:

1. Enteric Capsule Technology: This acid-resistant capsule is designed to bypass the stomach without dissolution, ensuring that DHB is not converted back to standard berberine HCl. This formula guarantees an effective release in the small intestine where absorption occurs most efficiently.

2. DiBerberine™ Proprietary Blend: Each capsule contains a potent 500mg of DHB. Research demonstrates that a mere 100mg dose results in approximately 6.7 times greater plasma exposure compared to the conventional 500mg of standard berberine HCl. This significant pharmacokinetic advantage highlights the superior effectiveness of DiBerberine 300x.

3. RGBooster1™: This unique component is a patent-pending flavonoid complex that enhances the absorption process. Utilization of Sophora japonica extract, known for its efficacy, shows up to 300 times more potency than piperine in modulating the P-gp active transport mechanism, thus assisting in the bioavailability of nutrients.

Loera emphasizes, “While enteric coating isn't new, applying it to DHB was a logical step—one that had yet to be realized in a commercially available product.” This fresh perspective on the combination of traditional pharmaceutical techniques with nutritional supplements could change the landscape of health and wellness products substantially.

Product Availability and Market Reach

Manufactured in the USA adhering to cGMP standards and thoroughly tested by third parties, DiBerberine 300x is now up for purchase on their website, revgenetics.com. A month’s supply, containing 30 enteric capsules, is priced at $44.95. This pricing structure positions the product competitively in the marketplace, promising both quality and affordability.

In a bid to broaden their outreach, RevGenetics is also launching an affiliate program, catering to health and wellness influencers, health practitioners, and marketers eager to partner. They can access this opportunity via getlink.revgenetics.com.

Conclusion

As the supplement industry grapples with the challenges of bioavailability and efficacy, RevGenetics stands apart by innovating within the critical gaps of existing products. DiBerberine 300x is more than just a supplement; it embodies a new paradigm in health, addressing fundamental metabolic support challenges while setting a higher standard for product integrity and consumer trust. With its groundbreaking approach, RevGenetics could well redefine the future of supplement delivery systems and metabolic health solutions.